SBC Medical Group Holdings Incorporated carries a market capitalization of 329.11M, placing it among publicly traded companies globally. Its enterprise value stands at 329.13M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 329.11M |
| Enterprise Value | 329.13M |
SBC Medical Group Holdings Incorporated currently has 102.58M shares outstanding.
| Shares Outstanding | 102.58M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
SBC Medical Group Holdings Incorporated trades at a trailing price-to-earnings ratio of 10.54. The price-to-sales ratio is 2.54, and the price-to-book ratio stands at 1.71.
| PE Ratio | 10.54 |
| PS Ratio | 2.54 |
| PB Ratio | 1.71 |
| P/TBV Ratio | 2.07 |
| P/FCF Ratio | 12.47 |
| P/OCF Ratio | 13.44 |
On an enterprise value basis, SBC Medical Group Holdings Incorporated trades at an EV/EBITDA multiple of 5.16 and an EV/FCF ratio of 9.50. The EV/Sales ratio of 1.94 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 5.40 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.94 |
| EV / EBITDA | 5.16 |
| EV / EBIT | 5.40 |
| EV / FCF | 9.50 |
SBC Medical Group Holdings Incorporated maintains a current ratio of 3.82, meaning it holds 3.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 19.19, indicating elevated leverage, while an interest coverage ratio of 236.76 demonstrates strong ability to service its debt obligations.
| Current Ratio | 3.82 |
| Quick Ratio | 3.61 |
| Debt / Equity | 19.19 |
| Debt / EBITDA | 0.81 |
| Interest Coverage | 236.76 |
SBC Medical Group Holdings Incorporated posts a return on equity of 17.63 and a return on invested capital of 12.37.
| Return on Equity (ROE) | 17.63 |
| Return on Assets (ROA) | 12.13 |
| Return on Invested Capital (ROIC) | 12.37 |
| Return on Capital Employed (ROCE) | 15.03 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 24.61 |
Over the trailing twelve months, SBC Medical Group Holdings Incorporated has paid 28.59M in income taxes, reflecting an effective tax rate of 41.15.
| Income Tax | 28.59M |
| Effective Tax Rate | 41.15 |
SBC Medical Group Holdings Incorporated's stock has declined approximately -33.8843% over the past 52 weeks. The 50-day moving average sits at 3.60, while the 200-day moving average is 3.95.
| Beta (5Y) | N/A |
| 52-Week Price Change | -33.8843% |
| 50-Day Moving Average | 3.60 |
| 200-Day Moving Average | 3.95 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, SBC Medical Group Holdings Incorporated generated 169.34M in revenue and converted that into 40.79M in net income, yielding earnings per share of 0.40. EBITDA reached 63.73M, while operating income came in at 61.00M.
| Revenue | 169.34M |
| Gross Profit | 119.90M |
| Operating Income | 61.00M |
| Pretax Income | 69.47M |
| Net Income | 40.79M |
| EBITDA | 63.73M |
| EBIT | 61.00M |
| Earnings Per Share (EPS) | 0.40 |
SBC Medical Group Holdings Incorporated holds 167.62M in cash and equivalents against 51.90M in total debt, resulting in a net debt position of -126.87M. Total book value stands at 251.77M, with working capital of 176.21M providing operational flexibility.
| Cash & Cash Equivalents | 167.62M |
| Total Debt | 51.90M |
| Net Debt | -126.87M |
| Equity (Book Value) | 251.77M |
| Book Value Per Share | 2.45 |
| Working Capital | 176.21M |
SBC Medical Group Holdings Incorporated produced 31.97M in operating cash flow over the past twelve months. After subtracting -2.50M in capital expenditures, free cash flow totaled 29.47M - equivalent to 0.29 per share.
| Operating Cash Flow | 31.97M |
| Capital Expenditures | -2.50M |
| Free Cash Flow | 29.47M |
| FCF Per Share | 0.29 |
SBC Medical Group Holdings Incorporated operates with a gross margin of 70.80, reflecting its pricing power and cost economics. The operating margin of 36.02 and net profit margin of 24.09 provide insight into operational efficiency.
| Gross Margin | 70.80 |
| Operating Margin | 36.02 |
| Pretax Margin | 41.02 |
| Profit Margin | 24.09 |
| EBITDA Margin | 37.63 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -8.55 |
| FCF Yield | 8.02 |
SBC Medical Group Holdings Incorporated posts an Altman Z-Score of 5.06, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.06 |